Avadel Pharmaceuticals Stock Options Expiring on 15th of January 2027
| AVDL Stock | USD 10.00 0.15 1.48% |
Avadel Pharmaceuticals' latest option contracts expiring on 2027-01-15 are carrying combined implied volatility of 0.09 with a put-to-call open interest ratio of 0.0 over 12 outstanding agreements suggesting investors are buying way more calls than puts on contracts expiring on 2027-01-15. The total put volume is at 5.0, with calls trading at the volume of 5.0. This yields a 0.05 put-to-call volume ratio.
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. Avadel Pharmaceuticals In The Money Call Balance
When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying Avadel Pharmaceuticals' options that are 'In the Money' or 'Out of the Money', the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
While 'out-of-the-money' option contracts written on Avadel Pharmaceuticals PLC are typically viewed as the more aggressive, there are potential upsides to purchasing these types of options contracts. For one, the cost to buy an 'Out of the Money' option is lower than the cost to buy an 'In the Money' option. This cost-benefit is due to the fact that at the time of the purchase, 'Out of the Money' contracts have no intrinsic value. So, while the potential for a 100% loss is more significant, the cost and risk to enter the trade are lower.
Avadel Current Options Market Mood
Avadel Pharmaceuticals' open interest and total value indicators provide investors with the necessary information to digest the overall options buildup for its expiring contracts. In addition, it helps Avadel Stock's traders understand whether a recent fall or rise in the market is unreasonable and if the time has come to take contrarian positions. These ratios are calculated based on options trading volumes and current open interest.
Put-to-Call Volume
Unfortunately, most Avadel Pharmaceuticals' options investors are not very successful. Avadel Pharmaceuticals' option open interest and volume spread between outstanding puts and calls are regarded by many investors as reliable indicators of the overall future market direction.
Rule 16 of the current Avadel contract
Base on the Rule 16, the options market is currently suggesting that Avadel Pharmaceuticals PLC will have an average daily up or down price movement of about 0.005413% per day over the life of the 2027-01-15 option contract. With Avadel Pharmaceuticals trading at USD 10.0, that is roughly USD 5.41E-4. If you think that the market is fully incorporating Avadel Pharmaceuticals' daily price movement you should consider buying Avadel Pharmaceuticals PLC options at the current volatility level of 0.0866%. But if you have an opposite viewpoint you should avoid it and even consider selling them.
Avadel |
Avadel Pharmaceuticals Option Chain
When Avadel Pharmaceuticals' strike price is surpassing the current stock price, the option contract against Avadel Pharmaceuticals PLC stock is said to be in the money. When it comes to buying options that are ITM or OTM, the choice depends on your outlook for the underlying security, financial situation, and what you are trying to achieve.
Avadel Pharmaceuticals' option chain is a display of a range of information that helps investors for ways to trade options on Avadel. In general, an option chain provides a helpful tool for investors to see all available option contracts, both puts, and calls, for Avadel. It also shows strike prices and maturity days for a Avadel Pharmaceuticals against a given expiration period. The table below combines all the option information in the form of a chain but before you use it, remember that it entails significant risk and it is not for everyone. | Open Int | Expiration | Current Spread | Last Price | |||
Call | AVDL Option Call 15-01-2027 5 | 0 | 2027-01-15 | 0.0 - 0.0 | 7.77 | In |
Call | AVDL Option Call 15-01-2027 7 | 0 | 2027-01-15 | 0.0 - 0.0 | 4.83 | In |
Call | AVDL Option Call 15-01-2027 10 | 0 | 2027-01-15 | 0.0 - 0.0 | 4.3 | |
Call | AVDL Option Call 15-01-2027 12 | 0 | 2027-01-15 | 0.0 - 0.0 | 2.97 | |
Call | AVDL Option Call 15-01-2027 15 | 0 | 2027-01-15 | 0.0 - 0.0 | 3.0 | |
Call | AVDL Option Call 15-01-2027 17 | 0 | 2027-01-15 | 0.0 - 0.0 | 5.0 | |
Call | AVDL Option Call 15-01-2027 20 | 0 | 2027-01-15 | 0.0 - 0.0 | 1.27 | |
Call | AVDL Option Call 15-01-2027 25 | 0 | 2027-01-15 | 0.0 - 0.0 | 1.1 | |
Put | AVDL Option Put 15-01-2027 7 | 0 | 2027-01-15 | 0.0 - 0.0 | 1.73 | |
Put | AVDL Option Put 15-01-2027 10 | 0 | 2027-01-15 | 0.0 - 0.0 | 3.2 | |
Put | AVDL Option Put 15-01-2027 12 | 0 | 2027-01-15 | 0.0 - 0.0 | 4.6 | In |
Put | AVDL Option Put 15-01-2027 17 | 1 | 2027-01-15 | 4.1 - 8.7 | 6.9 | In |
Avadel Pharmaceuticals Market Cap Over Time
Market Cap |
| Timeline |
Avadel Total Stockholder Equity
Total Stockholder Equity |
|
Avadel Pharmaceuticals Corporate Management
| Gregory Davis | VP Development | Profile | |
| Richard Kim | Chief Officer | Profile | |
| Christian PharmD | Chief Affairs | Profile | |
| Steven Sullivan | VP Operations | Profile | |
| Jason Vaughn | Senior Operations | Profile | |
| Jennifer PharmD | Senior Affairs | Profile |
Check out Trending Equities to better understand how to build diversified portfolios, which includes a position in Avadel Pharmaceuticals PLC. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in unemployment. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.
Is Pharmaceuticals space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Avadel Pharmaceuticals. If investors know Avadel will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Avadel Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.09) | Revenue Per Share 1.036 | Quarterly Revenue Growth 26.743 | Return On Assets (0.34) | Return On Equity (1.00) |
The market value of Avadel Pharmaceuticals is measured differently than its book value, which is the value of Avadel that is recorded on the company's balance sheet. Investors also form their own opinion of Avadel Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Avadel Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Avadel Pharmaceuticals' market value can be influenced by many factors that don't directly affect Avadel Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Avadel Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Avadel Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Avadel Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.